Cyberbiosecurity in the new normal: Cyberbio risks, pre-emptive security, and the global governance of bioinformation

Abstract

The Covid-19 pandemic saw a surge in cyber attacks targeting pharmaceutical companies and research organisations working on vaccines and treatments for the virus. Such attacks raised concerns around the (in)security of bioinformation (e.g. genomic data, epidemiological data, biomedical data, and health data) and the potential cyberbio risks resulting from stealing, compromising, or exploiting it in hostile cyber operations. This article critically investigates threat discourses around bioinformation as presented in the newly emerging field of ‘cyberbiosecurity’. As introduced by scholarly literature in life sciences, cyberbiosecurity aims to understand and address cyber risks engendered by the digitisation of biology. Such risks include, for example, embedding malware in DNA, corrupting gene-sequencing, manipulating biomedical materials, stealing epidemiological data, or even developing biological weapons and spreading diseases. This article brings the discussion on cyberbiosecurity into the realms of International Relations and Security Studies by problematising the futuristic threat discourses co-producing this burgeoning field and the pre-emptive security measures it advocates, specifically in relation to bioinformation. It analyses how cyberbiosecurity as a concept and field of policy analysis influences the existing securitised governance of bioinformation, the global competition to control it, and the inequalities associated with its ownership and dissemination. As such, the article presents a critical intervention in current debates around the intersection between biological dangers and cyber threats and in the calls for ‘peculiar’ policy measures to defend against cyberbio risks in the ‘new normal’.